Skip to main content
Nanoleaf showcases innovative tech including smart robots, red light therapy panels, AI integration, and upcoming Matter prot

Editorial illustration for Nanoleaf pushes robots, red‑light therapy, AI and upcoming Matter 1.4/1.5 support

Nanoleaf pushes robots, red‑light therapy, AI and...

Nanoleaf pushes robots, red‑light therapy, AI and upcoming Matter 1.4/1.5 support

2 min read

Nanoleaf has been unusually quiet. While Govee and Philips Hue have been rolling out new fixtures and features at a rapid clip, Nanoleaf has added only a handful of smart‑lighting products in the past two years. The lull isn’t accidental; the company is undergoing a “brand evolution” that leans into wellness, robotics and artificial intelligence. “The smart home is getting kind of boring,” says CEO and co‑founder Gimmy Chu, who now prefers not to label the firm a smart‑lighting company at all.

Known for its modular RGB panels and software that syncs lights to screens, Nanoleaf was an early adopter of Thread and Matter. Its 2020 smart bulb was among the first Thread devices to work with Apple’s HomePod Mini. Chu argues that open standards like Matter are turning smart lighting into a commodity, prompting the pivot toward robots, red‑light therapy and AI‑driven products. Upcoming support for Matter 1.4/1.5 hints at continued alignment with open ecosystems, even as the brand reaches beyond illumination.

But Chu says open standards like Matter are leading to the commodification of smart lighting — as evidenced by companies like Ikea selling full-color smart lightbulbs for around $10 that work with every platform.

Why this matters

Nanoleaf’s pivot to robotics, red‑light therapy and AI signals a shift from pure lighting to a broader wellness platform. For developers, the imminent Matter 1.4 support and a forthcoming Matter 1.5 product could simplify integration across ecosystems, assuming the standards hold up. Yet the company has released only a handful of lighting items in two years, so the depth of its new hardware lineup remains unclear.

If the “hard work” on underlying technology truly makes new lamp form factors easy, third‑party creators might find lower barriers to entry; still, we’ve yet to see concrete SDKs or open‑source tools. Founders should watch how Nanoleaf balances wellness claims with measurable performance, especially around red‑light therapy, where efficacy is often debated. Researchers may find a testbed for AI‑driven ambient environments, but the lack of detailed AI capabilities in the article leaves open questions about scalability.

In short, Nanoleaf’s announced roadmap offers intriguing possibilities, but its real impact will depend on execution and transparency.

Further Reading